Endava plc (DAVA) Income Statement Analysis

See more : PDS Biotechnology Corporation (PDSB) Income Statement Analysis – Financial Results

Complete financial analysis of Endava plc (DAVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Endava plc, a leading company in the Software – Infrastructure industry within the Technology sector.

You may be interested

Endava plc (DAVA)

Industry: Software - Infrastructure

Sector: Technology

Website: https://www.endava.com

About Endava plc

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in Europe, Latin America, North America, and internationally. The company offers technology and digital advisory services for payments and financial services, and TMT sectors; IT strategies; business analysis services; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services. It also engages in the identifying, defining, and embedding collaborative data and analytics; and provision of automated testing, cloud native software engineering, continuous delivery, distributed agile delivery, intelligent automation, secure development, agile applications management, cloud infrastructure, DevSecOps, service delivery, smart desk, and telemetry and monitoring services. The company was founded in 2000 and is headquartered in London, the United Kingdom.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	740.76M	794.73M	654.76M	446.30M	350.95M	287.93M	217.61M	159.37M	115.43M	84.11M	63.91M	42.61M
Cost of Revenue	561.05M	530.66M	436.83M	292.47M	250.80M	189.10M	145.44M	108.76M	75.05M	52.28M	42.18M	28.16M
Gross Profit	179.71M	264.08M	217.93M	153.83M	100.15M	98.83M	72.17M	50.61M	40.39M	31.83M	21.73M	14.44M
Gross Profit Ratio	24.26%	33.23%	33.28%	34.47%	28.54%	34.32%	33.16%	31.76%	34.99%	37.84%	34.01%	33.90%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	135.30M	0.00	0.00	78.28M	65.86M	0.00	0.00	0.00	180.00K	150.00K	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	433.00K	333.00K	0.00
SG&A	159.57M	135.30M	121.81M	90.29M	78.28M	65.86M	46.74M	27.55M	20.45M	613.00K	483.00K	167.36K
Other Expenses	0.00	0.00	0.00	0.00	-49.00K	-5.95M	46.74M	27.55M	20.45M	0.00	0.00	0.00
Operating Expenses	159.57M	150.30M	121.81M	90.29M	78.28M	65.86M	46.74M	27.55M	20.45M	16.57M	12.02M	9.81M
Cost & Expenses	720.62M	680.96M	558.63M	382.76M	329.08M	254.96M	192.18M	136.31M	95.50M	68.85M	54.20M	37.98M
Interest Income	6.19M	3.90M	188.00K	104.00K	555.00K	486.00K	35.00K	18.00K	1.07M	56.00K	29.00K	94.13K
Interest Expense	6.27M	1.95M	1.51M	1.59M	1.08M	345.00K	818.00K	408.00K	170.00K	0.00	0.00	0.00
Depreciation & Amortization	38.94M	32.93M	28.97M	24.45M	18.25M	7.90M	6.27M	4.35M	2.88M	1.27M	1.22M	1.25M
EBITDA	72.19M	150.77M	96.86M	81.27M	19.66M	38.35M	31.49M	27.42M	23.88M	18.38M	11.18M	6.17M
EBITDA Ratio	9.75%	16.32%	14.79%	14.24%	5.60%	11.45%	11.69%	17.21%	20.69%	21.85%	17.50%	14.49%
Operating Income	20.14M	112.85M	67.89M	38.40M	932.00K	33.11M	25.43M	23.06M	19.93M	17.11M	9.97M	4.92M
Operating Income Ratio	2.72%	14.20%	10.37%	8.60%	0.27%	11.50%	11.69%	14.47%	17.27%	20.34%	15.60%	11.55%
Total Other Income/Expenses	6.84M	-7.21M	7.00M	-9.20M	5.28M	-2.87M	-783.00K	-1.36M	898.00K	-1.90M	-282.00K	-384.97K
Income Before Tax	26.98M	114.16M	102.38M	54.36M	25.26M	30.10M	24.65M	21.70M	20.83M	15.21M	9.69M	4.54M
Income Before Tax Ratio	3.64%	14.36%	15.64%	12.18%	7.20%	10.45%	11.33%	13.62%	18.05%	18.08%	15.15%	10.64%
Income Tax Expense	9.86M	20.00M	19.29M	10.91M	3.85M	6.09M	5.68M	4.87M	4.13M	1.66M	1.54M	211.34K
Net Income	17.12M	94.16M	83.09M	43.45M	19.99M	24.01M	18.98M	16.83M	16.71M	13.55M	8.15M	4.75M
Net Income Ratio	2.31%	11.85%	12.69%	9.74%	5.70%	8.34%	8.72%	10.56%	14.47%	16.11%	12.75%	11.14%
EPS	0.29	1.62	1.48	0.79	0.40	0.44	0.38	0.32	0.32	0.29	0.16	0.12
EPS Diluted	0.29	1.62	1.43	0.76	0.38	0.44	0.38	0.32	0.32	0.29	0.16	0.12
Weighted Avg Shares Out	58.44M	57.31M	56.27M	55.22M	53.42M	54.56M	49.80M	53.00M	53.00M	46.71M	49.68M	39.75M
Weighted Avg Shares Out (Dil)	58.80M	58.08M	58.02M	57.05M	56.07M	55.03M	49.80M	53.00M	53.00M	46.81M	49.86M	39.75M

The Gross Law Firm Notifies Endava plc Investors of a Class Action Lawsuit and Upcoming Deadline – DAVA

October 16, 2024globenewswire.com

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Endava plc (NYSE: DAVA).

Endava plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 25, 2024 to Discuss Your Rights - DAVA

October 16, 2024accesswire.com

NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Endava plc (NYSE:DAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more...

DAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Endava plc Stockholders Have Opportunity to Lead Class Action Lawsuit!

October 16, 2024accesswire.com

NEW YORK CITY, NY / ACCESSWIRE / October 16, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Endava plc ("Endava" or "the Company") (NYSE:DAVA) and...